0001209191-15-070808.txt : 20150915
0001209191-15-070808.hdr.sgml : 20150915
20150915173457
ACCESSION NUMBER: 0001209191-15-070808
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150914
FILED AS OF DATE: 20150915
DATE AS OF CHANGE: 20150915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGowan Pauline
CENTRAL INDEX KEY: 0001594782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 151108495
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-14
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001594782
McGowan Pauline
C/O CONCERT PHARMACEUTICALS, INC.
99 HAYDEN AVENUE, SUITE 500
LEXINGTON
MA
02421
0
1
0
0
VP, Finance
Common Stock
2015-09-14
4
M
0
497
3.50
A
497
D
Common Stock
2015-09-14
4
S
0
497
18.9745
D
0
D
Employee Stock Option (right to buy)
3.50
2015-09-14
4
M
0
497
0.00
D
2021-12-12
Common Stock
497
498
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $18.79 to $19.25 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price
This option vested as to 6.25% of the original 7,964 shares on March 12, 2012 and vests as to an additional 6.25% of the original shares at the end of each successive three-month period through and including December 12, 2015.
/s/ Pauline McGowan
2015-09-15